Acrivon Therapeutics Inc (ACRV)

Finanzdaten der Acrivon Therapeutics Inc-Aktie (ACRV)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	6.20%18.67	19.90	20.12	19.69	22.65
Research and Development	8.72%13.84	15.17	14.75	13.65	16.18
Operating Income/Loss	6.20%-18.67	-19.90	-20.12	-19.69	-22.65
Nonoperating Income/Loss	18.14%0.70	0.86	1.13	1.45	1.64
	5.66%-17.96	-19.04	-18.99	-18.23	-21.01
Attributable To Parent	5.66%-17.96	-19.04	-18.99	-18.23	-21.01
Basic Average Shares	8.05%41.84	38.72	-	38.56	38.46
Diluted Average Shares	8.05%41.84	38.72	-	38.56	38.46
Basic Earnings Per Share	12.24%-0.43	-0.49	-	-0.47	-0.55
Diluted Earnings Per Share	12.24%-0.43	-0.49	-	-0.47	-0.55